Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins" report to their offering.

This report prepared provides a compilation of the sales data of originator recombinant therapeutic proteins and antibodies in the calendar year 2015. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets.

All sales data were converted from their original, reported currency into US$ using official currency exchange rates as of March 9, 2016. Sales figures represent the sum of revenues in all territories where the products are marketed. Growth rates mostly are presented as reported (not based on constant exchange rates).

A total of 39 biologic therapeutics reached blockbuster status with 2015 sales exceeding US$ 1 bln: 21 antibodies and 18 proteins. Nine biologics reached global sales in 2015 of more than US$ 5 bln. Four biologics were new in the blockbuster biologics list and one dropped out. Six biopharmaceutical companies posted combined biologics sales of more than US$ 10 bln in the year 2015.

Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2015 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2015 and the percentage of antibody sales of total biologics sales.

Key Topics Covered:

1. 2015 Biologics Sales per Class of Products

2. Blockbuster Biologics in 2015 (by generic name)

3. Company Ranking List for Biologics Sales 2015

4. Biologic Product Sales 2015

- Anti-TNF Antibodies

- Cancer Antibodies

- Insulin and Insulin Analogs

- Other Anti-Inflammatory and Anti-Autoimmune Antibodies

- Ophthalmic Antibodies

- Recombinant Coagulation Factors

- Erythropoietins

- G-CSF

- Interferon beta

- Enzyme Replacement Proteins (ERT)

- Cardiometabolic & Anti-Infective Antibodies

- Human Growth Hormone (hGH)

- Follicle Stimulating Hormone (FSH)

- Interferon alpha

- Other Proteins: Cardiometabolic, Cancer & Others

For more information visit http://www.researchandmarkets.com/research/wpl4mb/blockbuster

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Biopharmaceuticals